Learn More
A year and a half ago, PLOS Medicine announced a collaboration with the World Health Organization (WHO), inviting submission of articles to PLOS Medicine on the theme of ''no health without research'' [1]. That call for papers was intended to culminate in an open-access collection of original research and commentary articles to coincide with the launch in(More)
If medical journals and public health advocates are concerned with corporate conflicts of interest, inappropriate marketing to children, impotent self-regulation, and general flouting of the rules, why are we ignoring the alcohol industry? The crisis of confidence that surrounds the behavior and practices of Big Tobacco and Big Pharma [1,2]—bias in funded(More)
If you are an editor, author, reviewer, or reader of medical journals, or if you depend on your doctor or health care provider getting unbiased information from medical journals, then the 1,500 documents now hosted on the PLoS Medicine Web site [1] should make you very concerned and angry. Because, quite simply, the story told in these documents amounts to(More)
It is now just over six years [1] since many medical journals began requiring that trials be registered before considering the trial report for publication. Such a policy was set up explicitly to reduce what was considered to be widespread bias in favor of publication of ''positive'' trials and to ensure that all clinical trials be made public prior to(More)
The use of mobile electronic devices to support medical or public health practice, or m-health, is currently a hot topic. It has been predicted that by 2017 there will be ''more mobile phones than people'' on the planet [1], and currently three-quarters of the world's population have access to a mobile phone [2]. The World Health Organization (WHO) has(More)
There is growing recognition of the massive global burden of non-communicable diseases (NCDs) due to their prevalence, projected social and economic costs, and traditional neglect compared to infectious disease. The 2011 UN Summit, WHO 25×25 targets, and support of major medical and advocacy organisations have propelled prominence of NCDs on the global(More)
Medicalization analyses have roots in sociology and have critical usefulness for understanding contemporary health issues including the 'post-2015 global health agenda'. Medicalization is more complex than just 'disease mongering'--it is a process and not only an outcome; has both positive and negative elements; can be partial rather than complete; and is(More)
Noncommunicable diseases (NCDs), most often defined as chronic medical diseases including cardiovascular diseases (heart disease and stroke), cancer, chronic respiratory diseases (chronic obstructive pulmonary disease and asthma), and diabetes [1], are responsible for two-thirds of the world's deaths, one-fourth of which occur before the age of 60 years(More)
The pharmaceutical industry is at a critical point in its relationship to society. Much of the early promise of the pharmaceutical industry in revolutionizing health care has not continued, with pipelines for innovative drugs drying up (including in critical areas such as neglected diseases [1]), an increasing number of me-too drugs flooding the market, and(More)